Clinical Trial Update: Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic Leukemia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating immune factors associated with relapse in childhood B-lineage acute lymphoblastic leukemia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-acute Lymphoblastic Leukemia
• Leukemia Relapse

Snippet

Sponsor: University Hospital, Angers | Conditions: B Acute Lymphoblastic Leukemia, Leukemia Relapse | Phase 4 | Status: TERMINATED